State Of Wyoming Glaukos Corp Transaction History

State Of Wyoming

$723 Million
Q1 2025

A detailed history of State Of Wyoming transactions in Glaukos Corp stock. As of the latest transaction made, State Of Wyoming holds 3,300 shares of GKOS stock, worth $313,368. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,300

Previous 3,245 1.69%

Holding current value

$313,368

Previous $486,000 33.33%

% of portfolio

0.04%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$96.6 - $161.22 $5,313 - $8,867	55 Added 1.69%	3,300 $324,000
Q4 2024 Feb 14, 2025	BUY	$126.42 - $152.67 $9,102 - $10,992	72 Added 2.27%	3,245 $486,000
Q3 2024 Nov 14, 2024	BUY	$113.62 - $135.39 $14,884 - $17,736	131 Added 4.31%	3,173 $413,000
Q2 2024 Aug 14, 2024	BUY	$89.48 - $118.35 $25,770 - $34,084	288 Added 10.46%	3,042 $360,000
Q1 2024 May 13, 2024	BUY	$76.4 - $96.33 $21,086 - $26,587	276 Added 11.14%	2,754 $259,000
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $16,013 - $22,894	269 Added 12.18%	2,478 $196,000
Q3 2023 Nov 14, 2023	BUY	$69.23 - $79.09 $44,584 - $50,933	644 Added 41.15%	2,209 $166,000
Q2 2023 Aug 14, 2023	BUY	$45.44 - $71.21 $15,540 - $24,353	342 Added 27.96%	1,565 $111,000
Q1 2023 May 12, 2023	BUY	$43.88 - $52.48 $2,457 - $2,938	56 Added 4.8%	1,223 $61,000
Q4 2022 Feb 14, 2023	SELL	$40.82 - $57.75 $90,171 - $127,569	-2,209 Reduced 65.43%	1,167 $50,000
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $69,135 - $86,331	1,476 Added 77.68%	3,376 $180,000
Q2 2022 Aug 15, 2022	BUY	$34.86 - $63.77 $66,234 - $121,163	1,900 New	1,900 $87,000

Others Institutions Holding GKOS

# of Institutions

358

Shares Held

50.2M

Call Options Held

260K

Put Options Held

776K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.52B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account